Private Equity, Platforms, Roll-Ups, EBITDA, and Multiples: A Plain-English Guide for Aesthetics Practice Owners

By Tommy Newton, Principal, Xite

The aesthetics industry is attracting more attention from private equity groups, strategic buyers, and multi-location operators. For many med spa and aesthetics practice owners, this creates exciting opportunities — but it also introduces a new language that can feel confusing, overly technical, or intimidating.

Terms like “platform,” “roll-up,” “EBITDA,” “multiple,” and “enterprise value” get used often in conversations about practice sales and partnerships. But most owners did not build their businesses by studying finance. They built them by serving patients, training teams, managing providers, creating a brand, and growing revenue one relationship at a time.

This article is designed to explain the basic terms in plain English.

Private Equity

Private equity, often called “PE,” refers to investment firms that raise money from investors and use that capital to buy, grow, and eventually sell businesses.

In the aesthetics industry, a private equity group may invest in a med spa platform, help it acquire additional practices, improve operations, expand locations, and then sell the larger company in the future.

Private equity groups are usually not buying a med spa just because they like the space. They are buying because they believe the business can grow, become more profitable, and become more valuable over time.

For owners, this can create an opportunity to sell part or all of the business, gain a growth partner, take some chips off the table, and participate in the future upside of a larger organization.

Platform

A “platform” is usually the first or foundational company that a private equity group invests in within a specific industry.

In aesthetics, a platform might be a strong med spa group with multiple locations, solid leadership, good systems, strong revenue, and a scalable brand. The platform becomes the base that future acquisitions are added onto.

Think of the platform as the hub. Other practices may later be acquired and connected to that hub.

A private equity group typically wants a platform to have more than just revenue. They want leadership, infrastructure, reporting, compliance, marketing systems, training processes, and the ability to support future growth.

Add-On Acquisition

An “add-on” is a smaller business acquired by the platform after the initial platform investment.

For example, if a private equity-backed aesthetics platform buys a successful single-location med spa in another market, that med spa may be considered an add-on acquisition.

The goal is usually to combine businesses under a larger organization, create efficiencies, expand geography, add talent, grow revenue, and increase the value of the overall company.

For many owners, selling to a platform as an add-on can be attractive because the buyer may already understand the industry, have operational resources, and know how to integrate the business.

Roll-Up

A “roll-up” is a strategy where a buyer acquires multiple smaller businesses in the same industry and combines them into a larger company.

The aesthetics industry is highly fragmented, meaning there are many independent med spas and aesthetic practices across the country. That fragmentation creates an opportunity for roll-ups.

A buyer may believe that 20 strong med spas operating together are worth more than 20 med spas operating separately. By combining businesses, the buyer may gain better vendor pricing, stronger marketing, shared systems, better recruiting, improved data, and a more valuable organization.

In simple terms, a roll-up is about taking many smaller businesses and building one larger business.

EBITDA

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization.

That sounds complicated, but the concept is simple.

EBITDA is a way buyers estimate the cash flow or profitability of a business before certain accounting and financing expenses.

For a med spa owner, EBITDA is often one of the most important numbers in a sale process because many buyers value businesses based on a multiple of EBITDA.

For example, if a practice has $1 million of EBITDA and a buyer values it at 6x EBITDA, the implied value would be $6 million.

That does not always mean the owner receives $6 million in cash at closing. Deal structure, debt, working capital, taxes, rollover equity, seller notes, earnouts, and other items can all affect the final outcome.

But EBITDA is often the starting point for valuation conversations.

Adjusted EBITDA

Adjusted EBITDA is EBITDA with certain expenses added back or adjusted to better reflect the true earnings of the business.

For example, a med spa owner may run personal expenses through the business, pay themselves above or below market compensation, or have one-time legal, consulting, recruiting, or buildout expenses.

A buyer may adjust EBITDA to account for those items.

The goal is to answer this question: “What would the business earn under normal operations with a market-based cost structure?”

Adjusted EBITDA is important because a higher, supportable adjusted EBITDA can increase the value of the business. However, adjustments need to be credible and well-documented. Buyers will not simply accept every add-back without review.

Multiple

A “multiple” is the number applied to EBITDA to estimate value.

For example:

If a business has $1 million of EBITDA and sells for a 7x multiple, the value would be $7 million.

If the same business sells for a 5x multiple, the value would be $5 million.

The multiple is influenced by many factors, including size, growth rate, profitability, provider dependency, recurring revenue, management team, brand strength, compliance, location, service mix, patient retention, and how transferable the business is after the owner exits.

In general, larger, more profitable, better-organized businesses tend to command higher multiples than smaller, owner-dependent businesses.

Enterprise Value

Enterprise value is the total value of the business before certain adjustments.

If a buyer says they are valuing a practice at $10 million, they may be referring to enterprise value.

However, enterprise value is not always the same as the amount of cash the seller receives at closing. The final proceeds can be affected by debt payoff, transaction expenses, working capital adjustments, taxes, seller financing, earnouts, and rollover equity.

This is why owners should not focus only on the headline purchase price. The structure of the deal can be just as important as the stated valuation.

Rollover Equity

Rollover equity means the seller reinvests a portion of their sale proceeds into the new company.

For example, an owner might sell 70% of the business and “roll over” 30% into the larger platform.

The idea is that the seller gets meaningful liquidity at closing while still retaining ownership in the future upside of the larger company.

If the platform grows and sells again later at a higher valuation, the seller’s rollover equity could become valuable. This future sale is often referred to as the “second bite of the apple.”

However, rollover equity also carries risk. The future value depends on the performance of the larger company, market conditions, debt levels, management execution, and the terms of the equity. Owners should understand exactly what they are rolling into.

Earnout

An earnout is a portion of the purchase price that is paid later if the business achieves certain performance targets.

For example, a buyer may agree to pay additional money if the practice hits a revenue or EBITDA goal after closing.

Earnouts can help bridge a valuation gap between buyer and seller. The seller believes the business is worth more because of future growth. The buyer may be willing to pay more, but only if that growth actually happens.

Earnouts can be useful, but they should be carefully structured. Owners need to understand the targets, timing, control, reporting, and what could prevent the earnout from being achieved.

Seller Note

A seller note means the buyer pays part of the purchase price over time instead of paying it all in cash at closing.

For example, a buyer may pay 80% at closing and the remaining 20% through a note over several years.

Seller notes can make deals easier to complete, but they also introduce risk because the seller is waiting to receive part of the money. The strength of the buyer, the repayment terms, security, interest rate, and default provisions all matter.

Quality of Earnings

A Quality of Earnings report, often called a “QoE,” is a financial review usually performed by an accounting firm during a transaction.

The purpose is to verify the company’s revenue, expenses, EBITDA, add-backs, trends, and financial quality.

A QoE helps the buyer understand whether the earnings are real, recurring, and sustainable.

For sellers, this can feel invasive because the buyer is examining financials in detail. But it is a normal part of many professional M&A transactions, especially when private equity is involved.

Due Diligence

Due diligence is the buyer’s investigation of the business before closing.

This may include reviewing financials, tax returns, payroll, leases, provider agreements, patient data, compliance, licenses, marketing, equipment, software, legal matters, HR policies, and contracts.

The buyer wants to confirm that the business is what they thought they were buying.

For owners, due diligence can be time-consuming. Preparation matters. Clean books, organized documents, clear reporting, and strong compliance can make the process smoother and help preserve value.

Letter of Intent

A Letter of Intent, or LOI, is a document that outlines the basic proposed terms of a transaction.

It usually includes the purchase price, structure, timing, exclusivity period, rollover equity, financing assumptions, and other major business terms.

An LOI is typically not the final purchase agreement. However, it is very important because it sets the framework for the deal.

Owners should take the LOI seriously. Once signed, it can be difficult to renegotiate major terms unless new information comes up during due diligence.

Purchase Agreement

The purchase agreement is the final legal document that governs the sale.

It includes the detailed terms of the transaction, including purchase price, representations and warranties, indemnification, closing conditions, post-closing obligations, employment agreements, restrictive covenants, and other legal protections.

This is where the details matter. Two deals with the same headline purchase price can have very different risk profiles depending on the purchase agreement.

Why These Terms Matter

Understanding these terms helps owners ask better questions, compare offers more effectively, and avoid being distracted by headline numbers.

A high valuation may not be the best deal if most of the consideration is tied to a risky earnout. A lower valuation with more cash at closing may be more attractive in certain situations. Rollover equity may create meaningful upside, but only if the owner understands the platform, the capital structure, and the future exit strategy.

The best deal is not always the one with the highest stated price. The best deal is the one that aligns with the owner’s goals, risk tolerance, timeline, team, and future role.

Final Thoughts

The aesthetics industry is becoming more sophisticated. As private equity and strategic buyers continue to evaluate med spas and aesthetic practices, owners will increasingly hear financial and M&A terminology.

You do not need to become an investment banker to understand your options. But you do need to understand the basic language.

The more educated you are before a buyer conversation begins, the better prepared you will be to evaluate opportunities, protect what you have built, and make confident decisions about the future of your practice.

About the Author

Tommy Newton is the Principal of Xite, a sell-side M&A and healthcare real estate advisory firm specializing in dental, medical, MedSpa, dermatology, plastic surgery, urgent care, and freestanding emergency center transactions. With over 20 years of experience in healthcare practice sales, private equity partnerships, real estate, and strategic growth consulting, Tommy has advised hundreds of practice owners across the U.S. on maximizing value in competitive markets.

About Xite

Xite is a leading sell-side M&A, practice brokerage, and real estate firm representing healthcare providers nationwide. We specialize in helping dental, medical, MedSpa, plastic surgery, dermatology, urgent care, and FEC owners sell their practices, find private equity partners, or execute strategic growth plans. Our data-driven approach, industry relationships, and deep transaction expertise ensure that our clients achieve optimal outcomes while maintaining confidentiality and control throughout the process.

For more information, visit https://xiteco.com.